IDP-023

Phase 1/2 Study of IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers

Near Add Your Location

Sorting 10 by

  • Accepting patients
  • Accepting patients
  • Accepting patients
  • Show Principal Investigator
  • Accepting patients
Sarah Cannon Research Institute
TriStar Centennial Medical Center
Nashville, TN
  • Accepting patients
  • Accepting patients
University Hospitals Seidman Cancer Center
Seidman Cancer Center at UH Case Medical
Cleveland, OH
  • Accepting patients
  • Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print a patient-friendly report to share with your patient.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.